CYPRESS BIOSCIENCE INC (CYPB) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 514 transactions totaling $11.1M, demonstrating a bearish sentiment with -$7.3M in net insider flow. The most recent transaction on Dec 28, 2010 involved a sale of 25,000 shares valued at $161.5K.
No significant insider buying has been recorded for CYPB in the recent period.
No significant insider selling has been recorded for CYPB in the recent period.
Based on recent SEC filings, insider sentiment for CYPB is bearish with an Insider Alignment Score of 17/100 and a net flow of -$7.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CYPRESS BIOSCIENCE INC (CYPB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading CYPB stock, having executed 514 transactions in the past 90 days. The most active insider is Jay D. Kranzler (Executive), who has made 402 transactions totaling $8.0M.
Get notified when executives and directors at CYPB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 28, 2010 | D. Kranzler Jay | Executive | Sale | 25,000 | $6.46 | $161.5K | |
| Dec 28, 2010 | D. Kranzler Jay | Executive | Option Exercise | 25,000 | $3.25 | $81.3K | |
| Dec 23, 2010 | D. Kranzler Jay | Executive | Sale | 152,464 | $6.45 | $983.4K | Large |
| Dec 23, 2010 | D. Kranzler Jay | Executive | Option Exercise | 152,464 | $3.25 | $495.5K | |
| Dec 20, 2010 | Srinivas Rao | Executive | Sale | 7,500 | $6.44 | $48.3K | |
| Dec 20, 2010 | Srinivas Rao | Executive | Option Exercise | 7,500 | $4.75 | $35.6K | |
| Jul 15, 2010 | Michael Gendreau R. | Executive | Purchase | 10,000 | $2.13 | $21.3K | |
| Jul 8, 2010 | Michael Gendreau R. | Executive | Purchase | 5,000 | $2.21 | $11.1K | |
| Jan 4, 2010 | D. Kranzler Jay | Executive | Award | 100,000 | $N/A | $0 | |
| Nov 9, 2009 | Walsh Michael | Executive | Purchase | 5,000 | $6.00 | $30.0K | |
| Aug 3, 2009 | D. Kranzler Jay | Executive | Sale | 75,000 | $8.69 | $651.8K | Large |
| Aug 3, 2009 | D. Kranzler Jay | Executive | Option Exercise | 75,000 | $2.51 | $188.3K | |
| Jul 6, 2009 | D. Kranzler Jay | Executive | Option Exercise | 75,000 | $2.51 | $188.3K | |
| Jul 6, 2009 | D. Kranzler Jay | Executive | Sale | 75,000 | $8.70 | $652.5K | Large |
| Mar 2, 2009 | D. Kranzler Jay | Executive | Option Exercise | 75,000 | $2.51 | $188.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 434 | $9.2M | 58.3% |
Exercise(M) | 54 | $3.7M | 23.5% |
Purchase(P) | 17 | $1.9M | 12.1% |
Payment(F) | 3 | $967.5K | 6.2% |
Award(A) | 1 | $0 | 0.0% |
Gift(G) | 5 | $0 | 0.0% |
Insider selling pressure at CYPRESS BIOSCIENCE INC has increased, with 9 insiders executing 514 transactions across all time. Total sales of $9.2M significantly outpace purchases of $1.9M, resulting in a net outflow of $7.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.